Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
PurposeThe clinical utility of screening unselected individuals for pathogenic BRCA1/2 variants has not been established. Data on cancer risk management behaviors and diagnoses of BRCA1/2-associated cancers can help inform assessments of clinical utility.MethodsWhole-exome sequences of participants in the MyCode Community Health Initiative were reviewed for pathogenic/likely pathogenic BRCA1/2 variants. Clinically confirmed variants were disclosed to patient-participants and their clinicians. We queried patient-participants' electronic health records for BRCA1/2-associated cancer diagnoses and risk management that occurred within 12 months after results disclosure, and calculated the percentage of patient-participants of eligible age who had begun risk management.ResultsThirty-seven MyCode patient-participants were unaware of their pathogenic/likely pathogenic BRCA1/2 variant, had not had a BRCA1/2-associated cancer, and had 12 months of follow-up. Of the 33 who were of an age to begin BRCA1/2-associated risk management, 26 (79%) had performed at least one such procedure. Three were diagnosed with an early-stage, BRCA1/2-associated cancer-including a stage 1C fallopian tube cancer-via these procedures.ConclusionScreening for pathogenic BRCA1/2 variants among unselected individuals can lead to occult cancer detection shortly after disclosure. Comprehensive outcomes data generated within our learning healthcare system will aid in determining whether population-wide BRCA1/2 genomic screening programs offer clinical utility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Cited by
Exome sequencing and characterization of 49,960 individuals in the UK Biobank
Van Hout, C. V., Tachmazidou, I., Backman, J. D., Hoffman, J. D., Liu, D., Pandey, A. K., Gonzaga-Jauregui, C., Khalid, S., Ye, B., Banerjee, N., et al. (2020) · Nature · doi:10.1038/s41586-020-2853-0 · Cited by 561
Self-citationPersonalized Medicine and the Power of Electronic Health Records
Abul-Husn, N. S., & Kenny, E. E. (2019) · Cell · doi:10.1016/j.cell.2019.02.039 · Cited by 355
Self-citationClinical outcomes of a genomic screening program for actionable genetic conditions
Buchanan, A. H., Lester Kirchner, H., Schwartz, M. L. B., Kelly, M. A., Schmidlen, T., Jones, L. K., Hallquist, M. L. G., Rocha, H., Betts, M., Schwiter, R., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0876-4 · Cited by 143
Self-citationVan Hout, C. V., Tachmazidou, I., Backman, J. D., Hoffman, J. X., Ye, B., Pandey, A. K., Gonzaga-Jauregui, C., Khalid, S., Liu, D., Banerjee, N., et al. (2019) · doi:10.1101/572347 · Cited by 110
Self-citation
Metadata
- Authors
- Buchanan, A. H., Manickam, K., Meyer, M. N., Wagner, J. K., Hallquist, M. L. G., Williams, J. L., Rahm, A. K., Williams, M. S., Chen, Z.-M. E., Shah, C. K., Garg, T. K., Lazzeri, A. L., Schwartz, M. L. B., Lindbuchler, D. M., Fan, A. L., Leeming, R., Servano, P. O., Smith, A. L., Vogel, V. G., Abul-Husn, N. S., Dewey, F. E., Lebo, M. S., Mason-Suares, H. M., Ritchie, M. D., Davis, F. D., Carey, D. J., Feinberg, D. T., Faucett, W. A., Ledbetter, D. H., & Murray, M. F.
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 20
- Issue
- 5
- Pages
- 554-558
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W2765196994
- Cited by
- 56
- References
- 1
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants. https://app.cochat.ai/papers/10.1038/gim.2017.145
- The paper
- Buchanan, A. H., Manickam, K., Meyer, M. N., Wagner, J. K., Hallquist, M. L. G., Williams, J. L., Rahm, A. K., Williams, M. S., Chen, Z.-M. E., Shah, C. K., Garg, T. K., Lazzeri, A. L., Schwartz, M. L. B., Lindbuchler, D. M., Fan, A. L., Leeming, R., Servano, P. O., Smith, A. L., Vogel, V. G., . . . Murray, M. F. (2018). Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants. Genetics in Medicine. https://doi.org/10.1038/gim.2017.145
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.